SCSuna Li Cranfill

Suna Li Cranfill

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Suna Li Cranfill has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Adam Yongxin Ye

    Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School

    1 shared publication
  • Alejandra Lozada

    Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania

    1 shared publication
  • Alex Ahn

    Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania

    1 shared publication
  • Amanda Hsieh

    Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania

    1 shared publication
  • Amy Wang

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, 91125, USA

    1 shared publication
  • Andrew Giovanni

    Sunovion Pharmaceuticals, Marlborough, MA, 01752, USA

    1 shared publication

Latest Publications

  • Open Access

    Scratch-AID, a deep learning-based system for automatic detection of mouse scratching behavior with high accuracy

    by Huasheng Yu, Jingwei Xiong, Adam Yongxin Ye, Suna Li Cranfill, Tariq Cannonier, Mayank Gautam, Marina Zhang, Rayan Bilal, Jong-Eun Park, Yuji Xue, et al.

    Mice are the most commonly used model animals for itch research and for development of anti-itch drugs. Most laboratories manually quantify mouse scratching behavior to assess itch intensity. This process is labor-intensive and limits large-scale genetic or drug screenings. In this study, we developed a new system, Scratch-AID (Automatic Itch Detection), which could automatically identify and quantify mouse scratching behavior with high accuracy. Our system included a custom-designed videotaping box to ensure high-quality and replicable mouse behavior recording and a convolutional recurrent neural network trained with frame-labeled mouse scratching behavior videos, induced by nape injection of chloroquine. The best trained network achieved 97.6% recall and 96.9% precision on previously unseen test videos. Remarkably, Scratch-AID could reliably identify scratching behavior in other major mouse itch models, including the acute cheek model, the histaminergic model, and a chronic itch model. Moreover, our system detected significant differences in scratching behavior between control and mice treated with an anti-itch drug. Taken together, we have established a novel deep learning-based system that could replace manual quantification for mouse scratching behavior in different itch models and for drug screening.


  • Open Access

    Identification of pathways that regulate circadian rhythms using a larval zebrafish small molecule screen

    by Eric A. Mosser, Cindy N. Chiu, T. Katherine Tamai, Tsuyoshi Hirota, Suna Li, May Hui, Amy Wang, Chanpreet Singh, Andrew Giovanni, Steve A. Kay, et al.

    The circadian clock ensures that behavioral and physiological processes occur at appropriate times during the 24-hour day/night cycle, and is regulated at both the cellular and organismal levels. To identify pathways acting on intact animals, we performed a small molecule screen using a luminescent reporter of molecular circadian rhythms in zebrafish larvae. We identified both known and novel pathways that affect circadian period, amplitude and phase. Several drugs identified in the screen did not affect circadian rhythms in cultured cells derived from luminescent reporter embryos or in established zebrafish and mammalian cell lines, suggesting they act via mechanisms absent in cell culture. Strikingly, using drugs that promote or inhibit inflammation, as well as a mutant that lacks microglia, we found that inflammatory state affects circadian amplitude. These results demonstrate a benefit of performing drug screens using intact animals and provide novel targets for treating circadian rhythm disorders.